Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Organisation › Details

Novartis Vaccines and Diagnostics Srl

https://www.novartisvaccines.it

	Start	2011-04-18 existent
	Group	GSK (Group)
	Industry	vaccine
	Industry 2	diagnostics (medical/biological)

	Region	Siena (SI)
	Country	Italy
	Street	1 Via Fiorentina
	City	53100 Siena (SI)
	Tel	+39-0577-243111
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for GSK (Group)

[1] GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio"....
[2] Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion"....
[3] CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA....
[4] GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London....
[5] Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London....
[6] GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London....
[7] LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren....
[8] GSK plc. (6/28/23). "Press Release: GSK Completes Acquisition of Bellus Health [For media and investors only]". London....
[9] GSK plc. (4/18/23). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Bellus Health [For media and investors only]". London....
[10] CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]